Maternal stress is a key risk factor in neurodevelopmental disorders, which often have a sex bias in severity and prevalence. We previously identified O-GlcNAc transferase (OGT) as a placental biomarker in our mouse model of early prenatal stress (EPS), where OGT levels were lower in male compared with female tissue and were further decreased following maternal stress. However, the function of placental OGT in programming the developing brain has not been determined. Therefore, we generated a transgenic mouse with targeted placental disruption of Ogt (Pl-OGT) and examined offspring for recapitulation of the adult EPS phenotype. Pl-OGT hemizygous and EPS male placentas showed similar robust changes in gene expression patterns suggestive of an altered ability to respond to endocrine and inflammatory signals, supporting placental OGT as an important mediator of EPS effects. ChIP-Seq for the O-GlcNAc mark identified the 17 beta hydroxysteroid dehydrogenase-3 (Hsd17b3) locus in male EPS placentas, which correlated with a reduction in Hsd17b3 expression and concordant reduced testosterone conversion. Remarkably, Pl-OGT adult offspring had reduced body weights and elevated hypothalamic-pituitary-adrenal stress axis responsivity, recapitulating phenotypes previously reported for EPS males. Further, hypothalamic microarray gene-set enrichment analyses identified reduced mitochondrial function in both Pl-OGT and EPS males. Cytochrome c oxidase activity assays verified this finding, linking reduced placental OGT with critical brain programming. Together, these studies confirm OGT as in important placental biomarker of maternal stress and demonstrate the profound impact a single placental gene has on longterm metabolic and neurodevelopmental programming that may be related to an increased risk for neurodevelopmental disorders.
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neurodevelopment | mitochondria | hypothalamus | 17b-HSD3 M aternal stress early in gestation has been identified as a risk factor for neurodevelopmental disorders, including autism spectrum disorders and schizophrenia. Despite strong epidemiological evidence, there remains a lack of specific mechanisms of disease development or predictive biomarkers of disease risk. Examination of the placenta is a promising avenue to find these mechanisms and biomarkers because of features of its biology and accessibility for diagnostic purposes postparturition. The placenta is uniquely positioned at the interface between the maternal and fetal compartments and is rapidly developing during the period of gestation at which maternal stress has been identified to increase disease risk to the offspring (1) (2) (3) (4) (5) . We previously identified a reduction in O-GlcNAc transferase (OGT), an important O-glycotransferase enzyme that plays a critical role in regulation of gene expression through chromatin remodeling, in male placentas following early prenatal stress (EPS) (4) . Placental OGT is basally lower in males due to its X-linkage and escaping of X-inactivation in the placenta and further reduced in our mouse model of EPS. Additionally, we established that a targeted reduction of placental OGT using transgenic mouse lines could significantly alter early hypothalamic brain development, supporting an important link between placental OGT and neurodevelopment.
Many of the programmatic changes produced in our EPS mouse model are endophenotypes of neurodevelopmental disorders, including stress dysregulation, cognitive dysfunction, and hypothalamic dysregulation of growth and development (4, (6) (7) (8) (9) (10) . These outcomes support the critical communication from the placenta to the fetus related to the bioenergetic or metabolic environment that then programs the hypothalamus, the brain's endocrine and metabolic regulatory center. To examine the potential function of OGT in the placenta and its downstream gene targets involved in transmission of the EPS phenotype, we used genetic and epigenetic methodologies to identify the functional intersection between a reduction in OGT and the effects of EPS in the placenta. Based on our hypothesis related to the energetic reprogramming of the hypothalamus resulting from reduced placenta OGT, adult mice from placental-specific OGT (Pl-OGT) hemizygous and homozygous knockout were examined for a recapitulation of an EPS phenotype.
Results
Effects of OGT Complement and EPS on Placental Gene Expression. To identify placental genes altered by a targeted reduction of placental OGT, we used a genome-wide microarray analysis. Gene expression was evaluated at embryonic day (E)12.5, because this gestational time point is a stage of development with a fully differentiated placenta and has been previously characterized to have significant differences in gene expression of OGT in response to EPS (4 Of these genes, 277 were down-regulated and 217 were up-regulated in X OGT-/X WT (Dataset S1). Functional annotation analyses reveal that the genes down-regulated with reduced placental OGT form five functional groupings: hormone/steroid biosynthesis, anti-inflammatory signaling, amine metabolism, glucagon signaling,
Significance
Early prenatal stress (EPS), a key risk factor for neurodevelopmental disorders, produces a marked reduction in O-GlcNAc transferase (OGT) in male placental tissue. In our current work, we determined that a targeted reduction of placental OGT recapitulates key features of EPS, including hypothalamic-pituitary-adrenal stress axis dysregulation, reduced postpubertal growth, and hypothalamic mitochondrial dysfunction. These results confirm that OGT serves as a key placental biomarker and functions as an important mediator of the maternal changes occurring in response to stress.
and NMDA receptor signaling. Similarly, genes up-regulated with reduced placental OGT were categorized into five functional groupings: protein folding, RNA polymerase I activity, RNA polymerase II activity, mRNA transport, and mitotic cell cycle.
To determine genes and pathways common to both reduced placental OGT and EPS, we performed a similar analysis comparing control placentas to EPS placentas at E12.5. There were 284 genes (both up-regulated and down-regulated; FDR < 0.05; Dataset S1) perturbed by EPS; direct comparison between the genes perturbed by reduced OGT and EPS reveal that only nine individual transcripts are dysregulated in the same direction. Despite the relatively few individual transcripts that share a similar pattern, functional annotation analyses that combine genes significantly changed in at least one of the four conditions (X To test whether OGT is directly involved in the transcription of genes perturbed both by reduced placental OGT and EPS, we first determined the transcripts most strongly linked by reducing the FDR to 0.01; this resulted in two genes, cold shock domain-containing protein C2 (down-regulated in X OGT-/X WT and EPS) and tRNA methyltransferase 11 (up-regulated in X OGT-/X WT and EPS). We then compared these genes' expression with OGT expression in control and EPS placentas. Trmt11 expression was negatively correlated with OGT expression (Fig. S1A ), but no relationship was found between Csdc2 and OGT expression (Fig. S1B) . Given that Trmt11 expression is elevated in both X OGT-/X WT and EPS placentas, and there is a negative correlation between OGT expression and Trmt11 expression, we hypothesized that OGT may be directly involved in the suppression of its transcription by modifying the locus with the posttranslational mark, O-GlcNAc. To test this hypothesis, we performed a ChIP-qPCR experiment in control and EPS placentas. O-GlcNAc patterns were higher in control than EPS placentas upstream of the transcription start site (Fig. S1C) but not downstream of the transcription start site.
Effects of Sex and EPS on O-GlcNAc and H3K4me3 Patterns in the Placenta. To further investigate the role of OGT in placental chromatin regulation, we performed a genome-wide ChIP-seq experiment at E12.5 comparing control and EPS placentas. For comparison purposes, we immunoprecipitated for both O-GlcNAc, a putative transcriptional repressive mark, and H3K4me3, a permissive chromatin mark. In control placentas, there were 18,676 O-GlcNAc peaks (over background; P < 0.05; Fig. 1A ) and 64,935 H3K4me3 peaks. In EPS placentas, there was very little change in H3K4me3 abundance compared with control (57,917 peaks), but O-GlcNAc peaks were reduced by over half (7,887 peaks); these results are consistent with the previously reported reduction of OGT expression in EPS placentas (4) . Irrespective of abundance, O-GlcNAc and H3K4me3 marks were consistently concentrated near the transcription start site of protein coding genes (∼90% of each mark within 10,000 bp of a transcription start site; Fig. 1A ), suggesting that O-GlcNAc is related to similar regulatory processes of gene transcription as H3K4me3.
Locus-specific examination of O-GlcNAc peaks in control and EPS placentas reveal there is a marked difference in gene function of loci modified by this mark between these groups. Control placental O-GlcNAc-associated loci are enriched for 11 functional annotations (FDR over background, <0.05; Dataset S2). Notably, over 20% of these loci involve vasculature development and over 30% involve extracellular signal transduction. EPS placental associated loci are enriched for only seven functional annotations (FDR < 0.05; Dataset S2). Of these loci, over 44% involve mitosis and less than 11% involve extracellular signal transduction. To examine the effects of chromatin state of a locus on its gene expression, we fit linear models to microarray expression values that included treatment and presence of an H3K4me3 and/or O-GlcNAc peak at that locus (Fig. 1B) . Unsurprisingly, a permissive H3K4me3 peak increased gene expression irrespective of treatment. An O-GlcNac peak on its own had no detectable effect on gene expression in either treatment. Interestingly, having both marks at a locus in control placentas increased gene expression further than H3K4me3 alone, whereas in EPS placentas, the opposite was true. Together, these data suggest that O-GlcNAc may affect gene expression by interacting with histone modifications and further that the nature of this interaction is treatment-dependent.
To determine any loci specifically involved in the male specific effects of EPS mediated by placental chromatin O-GlcNAc, we fit a generalized linear model to peak counts that included treatment, sex, and an interaction between the two predictors. We reasoned that any locus that has differential chromatin O-GlcNAc between male control and EPS placentas with a FDR of <0.05 and a log-fold change of at least 2 would represent a biologically meaningful difference based upon our previous ChIP-qPCR result using O-GlcNAc. Only one locus met these criteria, Hsd17b3, the enzyme that catalyzes the conversion of androstenedione to testosterone, with much less O-GlcNAc at this locus in EPS placentas (Fig. 1C) . Expression levels of Hsd17b3 were also much lower EPS placentas than control (Fig. 1C) . Functionally, these changes in O-GlcNAc and expression resulted in both higher androstenedione and lower testosterone in EPS placentas compared with controls (Fig. 1D) . Together, these data suggest that O-GlcNAc may in part regulate EPS-induced changes in Hsd17b3 expression in the placenta and further that this results in a lower prenatal testosterone production in EPS male placentas.
Effects of Reduced Placental OGT on Growth, Behavior, and Hypothalamic Development. To determine any long-term and programmatic changes resulting from reduced placental OGT, we compared X OGT-/Y, X OGT-/X WT , X OGT-/X OGT-to their same sex and WT littermates (X WT /Y and X WT /X WT ) from parturition to adulthood. No detectable differences between genotypes were identified for either anogenital distance (an early sign of sexual differentiation; P > 0.05) or body weights (P > 0.05; Fig. 2 A and B) before 5 wk of age. At 5 wk of age and continuing through 11 wk of age, X OGT-/Y had lower weights than their WT littermates ( Fig. 2A) , and interestingly in females, there is a dose-response to placental OGT for body weights with X OGT-
Mice with reduced placental OGT also had reduced gonadal fat pad weights and shorter tibial lengths than their WT littermates ( Fig. 2 C and D) , indicating a shorter and leaner phenotype (Fig. 2E) . Behaviorally, there was no difference between genotypes in anxiety-like behavior (as measured by time in the light of the light-dark box in Fig. 2F ). Response to a restraint stress was affected by levels of placental OGT: male X OGT-/Y had an increased hypothalamic-pituitary-adrenal (HPA) response compared with WT littermates (Fig. 2G) /Y mice, 4 were also down-regulated in EPS mice (mitochondrial part, metabolic process, carbohydrate metabolic process, and cell redox; Fig. 3B ), and all are related to mitochondrial function. Additionally, differential expression analyses determined that of the genes affected by either reduced placental OGT or EPS, 110 were dysregulated in the same direction in the two manipulations (Dataset S3). One such gene, neuropeptide Y (NPY), was significantly decreased both by EPS and reduced placental OGT. Given these results, we hypothesized that the observed dysregulation of hypothalamic functioning in male mice with either reduced placental OGT or that experienced EPS may be in part regulated by altered mitochondrial functioning in this brain region. To test this hypothesis, we measured cytochrome c oxidase (CCO) activity, the rate-limiting step of the electron transport chain, from hypothalamic punches. Both EPS and X OGT-/Y mice had reduced CCO activity compared with their respective controls (Fig. 3C) . Together, these data suggest that there are common hypothalamic gene expression patterns dysregulated by both reduced placental OGT and EPS and further that these expression changes result in altered hypothalamic mitochondrial activity.
Discussion
Fetal antecedents, such as maternal stress, are associated with an increased risk for neurodevelopmental disorders, including schizophrenia and autism, often in a sex-specific manner. Our previous work identified reduced OGT as a placental biomarker of male-specific effects of EPS (4). Placental OGT, an important cellular and chromatin regulator, is basally expressed lower in males, and its expression is further reduced by maternal prenatal stress. Additionally, we reported that a targeted reduction of placental OGT resulted in profound disruption in early hypothalamic gene expression patterns. To determine a functional link between placental OGT and transmission of information important in programming changes in the brain, we examined placental gene expression and chromatin regulation patterns, as well as the adult phenotype of placental-specific OGT knockout mice for predictive validity of this EPS biomarker.
OGT broadly affects cellular functioning through the unique posttranslational modification, O-GlcNAc, on serine and threonine residues of over 1,000 different intracellular proteins (11) . Many of these protein targets (notably RNA polymerase II, histone deacetylase-2, Tet proteins, and core histone H2B) are part of chromatin structure or directly regulate chromatin confirmation (12) (13) (14) (15) (16) (17) . Therefore, we hypothesized that reduced placental OGT may be a mechanism through which EPS alters placental function. In support of this hypothesis, we found specific gene expression patterns that were common between EPS placentas and placentas from genetically reduced placental OGT. Specifically, we detected a reduction in expression in functional gene sets involved in endocrine and anti-inflammatory signaling and an increase in those genes important in mitosis and RNA/ DNA replication and cell cycling, suggesting that a reduction of OGT (either transgenically or by EPS) could account for profound changes in the endocrine function of the placenta and subsequent differences in the relay of important signals to the developing fetus. Similarly, we found by ChIP-Seq analyses that levels of O-GlcNAcylation followed a similar pattern, where the majority of O-GlcNAcylated loci in control tissues involved responses to extracellular signaling, whereas the largest portion of loci identified in EPS placentas were involved with mitosis. Together, these data suggest that normal placentas at this stage of development are fully differentiated and able to respond to environmental conditions, whereas EPS and placentas with reduced OGT may still be progressing through a stage of rapid cellular proliferation. Such outcomes support that maternal stress early in pregnancy promotes a delay in the maturation of the placenta through its effects on OGT, such as by altered epigenetic regulation of key developmental genes by OGT, O-GlcNAc, and its coregulators, including regulation of the recently identified demethylases, Tet1 and Tet2 (13, 18, 19) . Delayed placental maturation has been associated with various clinical complications, including placental insufficiency (20) , and has also been associated with altered neurodevelopment (21) . This may be an evolutionary advantage whereby growth and development are delayed because of a less favorable environment.
OGT has been linked to transcriptional control in both invertebrates and mammals, specifically via modification of RNA polymerase II and various transcription factors at the promoters of genes important for growth, nutrient sensing and immunity (22, 23) . Despite this linkage, there has not been a consensus as to the effects this modification has on expression of the associated locus, with some data suggesting a predominantly repressive role (24), whereas others have suggested a more permissive one (25) . This likely reflects the complex milieu of proteins involved at the promoters of genes, as well as the dynamic nature of the O-GlcNAc mark (26) , and emphasizes the importance of understanding tissue and locus-specific mechanisms. In this study, we found that O-GlcNAc had treatment-specific effects on placental transcription across the entire genome, but locus-specific effects were noted as well. On balance, O-GlcNAc appeared to have little effect on gene expression when the permissive histone mark, H3K4me3, was not detected at the locus. When both O-GlcNAc and H3K4me3 marks were present they appeared to synergistically increase expression of a locus in control placentas but had the opposite effect in EPS placentas. These data suggest that the contributions of placental OGT toward an EPS phenotype likely involve complex and locus specific interactions at the chromatin level that may impact placental function throughout gestation.
Focusing on specific loci that may be predictive of an EPS male phenotype, we identified Hsd17b3, the enzyme that catalyzes the conversion of androstenedione to testosterone. There was a significant reduction of O-GlcNAc at this locus in male EPS placentas compared with control and was further associated with a reduction in expression of the gene. Functionally, as would be predicted from reduced 17βHSD-3, male EPS placental tissue showed a significant increase in androstenedione levels and a significant reduction in testosterone. We have previously reported that EPS results in a dysmasculinization phenotype in first and second generation male offspring, including HPA axis hyperresponsivity, smaller testes, and a shortened anogenital distance (6) , and yet the specific mechanism for this reduction in masculinization has not been determined. Fetal testosterone is important in the organization of the sexually dimorphic brain, and de novo placental production of this hormone may be a significant contributor (27) (28) (29) (30) . In conjunction with our data, this suggests that OGT can regulate placental testosterone production, thus providing a functional mechanism for some aspects of the EPS dysmasculinized phenotype.
To determine a potential recapitulation of the EPS phenotype in Pl-OGT offspring to better link changes in placental function with hypothalamic reprogramming, we examined adult offspring for outcomes similar to those we previously reported for EPS mice (4, (6) (7) (8) (9) (10) . Similar to EPS mice, Pl-OGT mice showed slowed growth and weight gain compared to control littermates, resulting in a 10-20% difference in end weights as adults (10) . From birth through weaning, however, Pl-OGT mice were normal in these measures, showing no differences in body weights, suggesting that the effect may be driven by growth or gonadal hormone changes around puberty or related to the stress of weaning. Intriguingly, for this phenotype there was a gene dosage effect where in females, hemizygous Pl-OGT mice fell between WT and homozygous Pl-OGT for body-length and weight measurements, supporting the critical impact of tight regulation of OGT levels in the placenta on neurodevelopment.
In addition to the body weight phenotype, mice with reduced placental OGT also had HPA stress axis dysregulation. In recapitulation of male EPS mice, male Pl-OGT mice showed a heightened corticosterone response to a restraint stress but a normal recovery period (6, 9) . Although the effect was in the same direction in males as the EPS males, the effect size was modest, suggesting that placental OGT does not account for the entire phenotype found in EPS males. These data also suggest that the effect on the HPA sensitivity in these mice is at the level of the corticotropin-releasing factor neuron, possibly within the paraventricular nucleus as predicted from our array results, rather than the glucocorticoid receptor-mediated feedback in the ventral hippocampus. In contrast, and to our surprise, female hemi-and homozygous Pl-OGT mice showed the opposite effect, with a blunted HPA stress axis, an observation not previously found in female EPS mice. This sex-specific programming by placental OGT is intriguing because it points to a likely involvement of additional placental X-or Y-linked genes in determining adult stress axis programming.
OGT is an important cellular nutrient, stress, and immune sensor (16, 22, 31) . In the placenta, OGT appears to provide signals as to an altered environment (nutritive and/or stressors) that shapes hypothalamic circuits involved in long-term programming of energy homeostasis and stress responsivity in a sexdependent manner. To further examine this, we compared hypothalamic gene expression patterns in adult Pl-OGT male mice. Fitting with our hypothesis, functional gene-set analyses pointed to dramatic changes in genes involved in mitochondrial function and energy metabolism. These results are similar to our previously reported hypothalamic gene expression changes in the neonatal hypothalamus Pl-OGT mice (4). Amazingly, in our comparison with the EPS male hypothalamus, we found a very similar pattern of gene expression, suggesting reduced mitochondrial function. We also examined the microarray data with a gene candidate approach and found a specific reduction in expression of NPY, an important regulator of energy homeostasis and stress responsivity, supporting the hypothesis that dysregulation is at the level of the developing hypothalamus (32) . We used a CCO assay as a readout of mitochondria function and compared EPS and Pl-OGT mice. Results confirmed that in both EPS and Pl-OGT mice, hypothalamic mitochondria function was significantly reduced, linking placental OGT again to EPS brain programming. Hypothalamic mitochondrial dysfunction has previously been associated with altered whole-body growth and energy homeostasis, as well as stress-related depressive-like behaviors (33) (34) (35) (36) (37) (38) . Therefore, the observed phenotypes in male EPS and Pl-OGT mice (HPA hyperresponsivity and dysregulated energy homeostasis) appear to be, at least in part, the result of mitochondrial dysfunction programmed by a reduction in placental OGT during gestation.
Using both our EPS mouse model and a transgenic Pl-OGT mouse, these studies have demonstrated that placental gene expression and chromatin structure, subsequent offspring development, and hypothalamic mitochondrial function are all substantially altered by the reduction of one key placental gene, OGT. Importantly, there is a strong association between male biased neurodevelopmental disorders (e.g., autism spectrum disorders and schizophrenia) with metabolic (39, 40) and HPA (41, 42) dysregulation, providing face validity for our findings as to the importance of the tight regulation and functional level of this protein in the placenta. These studies demonstrate a remarkable linkage between placental OGT and programming of the developing hypothalamus capable of producing profound long-term metabolic dysregulation, predictive of neurodevelopmental disorders.
Methods
Animals. Male C57BL/6J and female 129S1/SvImJ mice were obtained from The Jackson Laboratories and subsequently used as breeding stock to produce C57BL/6J:129S1/SvImJ hybrids (F1 hybrids). F1 hybrid breeding pairs (n = 21) were checked daily at 0700 hours for copulation plugs; 1200 hours of the day that the plug was observed was considered to be E0.5. F1 hybrids were used for the prenatal stress experiments. For the placental specific reduction of OGT (Pl-OGT), double-heterozygous [B6.129-Ogt tm1Gwh /J (X OGT /X WT ); B6-CYP19-Cre (P.Cre EPS. Administration of chronic variable stress was performed as previously described (9) . Dams were randomly assigned to treatment groups to receive stress during days 1-7 of gestation (EPS; n = 13) or to a control (n = 14) nonstressed group. Pregnant mice assigned to the EPS group experienced each of the following stressors (in random order) on a different day of the EPS period: 60 min (beginning at 1300 hours) of fox odor exposure (1:5,000 2,4,5-trimethylthiazole; Acros Organics), 15 min of restraint (beginning at 1300 hours) in a modified 50-mL conical tube, 36 h of constant light, novel noise (White Noise/Nature Sound-Sleep Machine; Brookstone) overnight, three cage changes (at ∼0900, 1200, and 1500 hours) throughout the light cycle, saturated bedding (700 mL, 23°C water) overnight, and novel object (eight marbles of similar shape and color) exposure overnight. These stressors were selected to be nonhabituating and for not inducing pain or directly influencing maternal food intake, weight gain, or behavior (7). Additional methods may be found in SI Methods.
